Medytox Solutions, Inc. 4
4 · Medytox Solutions, Inc. · Filed Nov 16, 2015
Insider Transaction Report
Form 4
Lagan Seamus
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $10.00From: 2012-10-01Exp: 2022-12-31→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Common Stock
2015-11-02−1,030,000→ 0 total(indirect: By LLC) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $5.00From: 2012-10-01Exp: 2017-12-31→ Common Stock (1,000,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub") and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 421,927 shares of Rennova common stock.
- [F2]Cancelled pursuant to merger agreement and related transactions among Medytox, Merger Sub and Rennova.